Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Lowe

Showing results (331-340 of 591) with videos related to

Pageof 60
Sort By:
Oncogene|May 23, 2006
Targeting survivin via PI3K but not c-akt/PKB by anticancer drugs in immature neutrophilsS Martinelli, G Kostylina, V Niggli, et al.
Cell Reports|September 23, 2014
Inducible in vivo silencing of Brd4 identifies potential toxicities of sustained BET protein inhibitionJessica E Bolden, Nilgun Tasdemir, Lukas E Dow, et al.
Cancer|December 6, 2012
CITED2 is a novel direct effector of peroxisome proliferator-activated receptor γ in suppressing hepatocellular carcinoma cell growthKin-Fai Cheung, Junhong Zhao, Ying Hao, et al.
Antioxidants (Basel, Switzerland)|April 3, 2021
NAC and Vitamin D Restore CNS Glutathione in Endotoxin-Sensitized Neonatal Hypoxic-Ischemic RatsLauren E Adams, Hunter G Moss, Danielle W Lowe, et al.
Oncogene|January 28, 1998
Suppression of apoptosis by bcl-2 does not prevent p53-mediated control of experimental metastasis and anchorage dependenceM A Nikiforov, S S Kwek, R Mehta, et al.
Frontiers in Pharmacology|March 10, 2022
Introduction to the BioChemical Library (BCL): An Application-Based Open-Source Toolkit for Integrated Cheminformatics and Machine Learning in Computer-Aided Drug DiscoveryBenjamin P Brown, Oanh Vu, Alexander R Geanes, et al.
Nature Genetics|February 5, 2003
An epi-allelic series of p53 hypomorphs created by stable RNAi produces distinct tumor phenotypes in vivoMichael T Hemann, Jordan S Fridman, Jack T Zilfou, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 25, 2008
Topoisomerase levels determine chemotherapy response in vitro and in vivoDarren J Burgess, Jason Doles, Lars Zender, et al.
Cell|June 18, 2003
Rb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescenceMasashi Narita, Sabrina Nũnez, Edith Heard, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 3, 2019
MAP kinase and autophagy pathways cooperate to maintain RAS mutant cancer cell survivalChih-Shia Lee, Liam C Lee, Tina L Yuan, et al.
Pageof 60

Showing results (331-340 of 591) with videos related to

Sort By:
Pageof 60
Oncogene|May 23, 2006
Targeting survivin via PI3K but not c-akt/PKB by anticancer drugs in immature neutrophilsS Martinelli, G Kostylina, V Niggli, et al.
Cell Reports|September 23, 2014
Inducible in vivo silencing of Brd4 identifies potential toxicities of sustained BET protein inhibitionJessica E Bolden, Nilgun Tasdemir, Lukas E Dow, et al.
Cancer|December 6, 2012
CITED2 is a novel direct effector of peroxisome proliferator-activated receptor γ in suppressing hepatocellular carcinoma cell growthKin-Fai Cheung, Junhong Zhao, Ying Hao, et al.
Antioxidants (Basel, Switzerland)|April 3, 2021
NAC and Vitamin D Restore CNS Glutathione in Endotoxin-Sensitized Neonatal Hypoxic-Ischemic RatsLauren E Adams, Hunter G Moss, Danielle W Lowe, et al.
Oncogene|January 28, 1998
Suppression of apoptosis by bcl-2 does not prevent p53-mediated control of experimental metastasis and anchorage dependenceM A Nikiforov, S S Kwek, R Mehta, et al.
Frontiers in Pharmacology|March 10, 2022
Introduction to the BioChemical Library (BCL): An Application-Based Open-Source Toolkit for Integrated Cheminformatics and Machine Learning in Computer-Aided Drug DiscoveryBenjamin P Brown, Oanh Vu, Alexander R Geanes, et al.
Nature Genetics|February 5, 2003
An epi-allelic series of p53 hypomorphs created by stable RNAi produces distinct tumor phenotypes in vivoMichael T Hemann, Jordan S Fridman, Jack T Zilfou, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 25, 2008
Topoisomerase levels determine chemotherapy response in vitro and in vivoDarren J Burgess, Jason Doles, Lars Zender, et al.
Cell|June 18, 2003
Rb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescenceMasashi Narita, Sabrina Nũnez, Edith Heard, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 3, 2019
MAP kinase and autophagy pathways cooperate to maintain RAS mutant cancer cell survivalChih-Shia Lee, Liam C Lee, Tina L Yuan, et al.
Pageof 60